Invention Grant
- Patent Title: Protein inhibitors to complement and VEGF pathways and methods of use thereof
-
Application No.: US14362109Application Date: 2012-11-30
-
Publication No.: US09988611B2Publication Date: 2018-06-05
- Inventor: Jeng-Horng Her , Huang-Tsu Chen
- Applicant: AP Biosciences, Inc. , Innovent Biologies, Inc.
- Applicant Address: TW Taipei KY George Town, Grand Cayman
- Assignee: AP Biosciences, Inc.,Innovent Biologics, Inc.
- Current Assignee: AP Biosciences, Inc.,Innovent Biologics, Inc.
- Current Assignee Address: TW Taipei KY George Town, Grand Cayman
- Agency: Morrison & Foerster LLP
- International Application: PCT/US2012/067489 WO 20121130
- International Announcement: WO2013/082563 WO 20130606
- Main IPC: C07K14/435
- IPC: C07K14/435 ; C12N9/12 ; C07K14/71 ; C07K14/47 ; C07K14/705 ; C07K16/00 ; A61K38/00
Abstract:
The invention provides bispecific fusion proteins that inhibit activation of complement pathway and vascular endothelial growth factor (VEGF) pathway and methods for using these fusion proteins.
Public/Granted literature
- US20150079084A1 PROTEIN INHIBITORS TO COMPLEMENT AND VEGF PATHWAYS AND METHODS OF USE THEREOF Public/Granted day:2015-03-19
Information query
